Treace Medical (TMCI) Concepts announced the successful completion of the first cases utilizing its SpeedAkin Anatomic Compression Implant, ACI. The SpeedAkin implant broadens the procedural versatility of Treace’s flagship SpeedPlate fixation platform, which is advancing a new standard in bone fusion fixation. Akin osteotomies are corrective straightening procedures of the great toe commonly performed in conjunction with bunion surgery1. SpeedAkin offers surgeons a unique anatomic implant that delivers dynamic titanium compression to stabilize the Akin osteotomy during healing.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMCI:
- Treace Medical ‘a rarer asset’ after Zimmer buys Paragon 28, says Lake Street
- Treace Medical Concepts Reports Strong 2024 Revenue Growth
- Treace Medical reports preliminary Q4 revenue $68.4M-$68.8M, consensus $67.02M
- CompoSecure to spin off Resolute, EHang raises Q4 revenue view; Morning Buzz
- Yum, Ralph Lauren upgraded: Wall Street’s top analyst calls